LVESVILeft Ventricular End Systolic Volume Index
References in periodicals archive ?
The primary end-point of the PARACHUTE China study was the assessment of efficacy as measured by the reduction in left ventricle end-systolic volume index (LVESVI) against baseline LVESVI at 3 months postdevice implantation.
The sample size of the trial was based upon an estimated change in LVESVI of 14 [+ or -] 14 ml/m [sup]2 from prior European and United States data.
A reduction in LVESVI of at least 15% was observed in significantly more patients with ivabradine than for placebo (38% vs.
The reduction in LVESVI of about 6 mL/m2 is more or less comparable with other pharmacologic interventions, and importantly it adds on to the beneficial effect of beta-blockers and ACE inhibitors," he said.